JSCRX
Price
$21.76
Change
+$0.20 (+0.93%)
Updated
Sep 11 closing price
Net Assets
3.23B
NRGEX
Price
$60.33
Change
+$0.38 (+0.63%)
Updated
Sep 11 closing price
Net Assets
6.95B
Interact to see
Advertisement

JSCRX vs NRGEX

JSCRX vs NRGEX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGEX has more cash in the bank: 6.95B vs. JSCRX (3.23B). NRGEX pays higher dividends than JSCRX: NRGEX (1.14) vs JSCRX (0.09). JSCRX was incepted earlier than NRGEX: JSCRX (22 years) vs NRGEX (5 years). JSCRX (1.56) is less costly to investors than NRGEX (0.68). JSCRX is a more actively managed with annual turnover of: 62.00 vs. NRGEX (23.00). JSCRX (0) and NRGEX (0) have matching initial minimum investment requirements. JSCRX annual gain was more profitable for investors over the last year : 8.40 vs. NRGEX (-7.42).
JSCRXNRGEXJSCRX / NRGEX
Total Expense Ratio1.310.026,550%
Annual Report Gross Expense Ratio1.560.68229%
Fund Existence22 years5 years-
Gain YTD12.64411.992105%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets3.23B6.95B46%
Annual Yield % from dividends0.091.148%
Returns for 1 year8.40-7.42-113%
Returns for 3 years32.814.97660%
Returns for 5 years-20.27N/A-
Returns for 10 years0.99N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSRX3.400.05
+1.64%
Nasus Pharma Ltd.
CV6.600.08
+1.23%
CapsoVision
LCID4.220.04
+0.96%
Lucid Group Inc
OXLCN24.51-0.07
-0.28%
Oxford Lane Capital Corp
GTLB46.99-0.31
-0.66%
GitLab